BCCIP: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''BRCA2 and CDKN1A-interacting protein''' is a [[protein]] that in humans is encoded by the ''BCCIP'' [[gene]].<ref name="pmid11313963">{{cite journal | vauthors = Liu J, Yuan Y, Huan J, Shen Z | title = Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2 | journal = Oncogene | volume = 20 | issue = 3 | pages = 336–45 |date=Apr 2001 | pmid = 11313963 | pmc = | doi = 10.1038/sj.onc.1204098 }}</ref><ref name="pmid10878006">{{cite journal | vauthors = Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H | title = TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase | journal = J Biol Chem | volume = 275 | issue = 40 | pages = 31145–54 |date=Oct 2000 | pmid = 10878006 | pmc = | doi = 10.1074/jbc.M003031200 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: BCCIP BRCA2 and CDKN1A interacting protein| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=56647| accessdate = }}</ref> | ||
}} | |||
{{ | |||
| | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. Several transcript variants encoding different isoforms have been described for this gene.<ref name="entrez" | | summary_text = This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. Several transcript variants encoding different isoforms have been described for this gene.<ref name="entrez" /> | ||
}} | }} | ||
==Interactions== | |||
BCCIP has been shown to [[Protein-protein interaction|interact]] with [[BRCA2]],<ref name=pmid11313963 /> [[P21]],<ref name=pmid10878006 /> and PTPmu ([[PTPRM]])<ref name="pmid18773424">{{cite journal| vauthors=Phillips-Mason PJ, Mourton T, Major DL, Brady-Kalnay SM| title=BCCIP associates with the receptor protein tyrosine phosphatase PTPmu. | journal=J Cell Biochem | year= 2008 | volume= 105 | issue= 4 | pages= 1059–72 | pmid=18773424 | doi=10.1002/jcb.21907 | pmc=2758318 | url= }}</ref> | |||
==References== | ==References== | ||
{{reflist| | {{reflist}} | ||
==External links== | |||
* {{UCSC gene info|BCCIP}} | |||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal | vauthors=Coleman RA, Rao P, Fogelsong RJ, Bardes ES |title=2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes. |journal=Biochim. Biophys. Acta |volume=1125 |issue= 2 |pages= 203–9 |year= 1992 |pmid= 1571364 |doi= 10.1016/0005-2760(92)90046-X}} | ||
*{{cite journal | | *{{cite journal | vauthors=Machackova E, Damborsky J, Valik D, Foretova L |title=Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic. |journal=Hum. Mutat. |volume=18 |issue= 6 |pages= 545 |year= 2002 |pmid= 11748848 |doi= 10.1002/humu.1232 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Armakolas A, Ladopoulou A, Konstantopoulou I |title=BRCA2 gene mutations in Greek patients with familial breast cancer. |journal=Hum. Mutat. |volume=19 |issue= 1 |pages= 81–2 |year= 2002 |pmid= 11754111 |doi= 10.1002/humu.9003 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Robson M, Scheuer L, Nafa K |title=Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. |journal=J. Med. Genet. |volume=39 |issue= 2 |pages= 126–8 |year= 2002 |pmid= 11836363 |doi= 10.1136/jmg.39.2.126| pmc=1735025 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Meng X, Liu J, Shen Z |title=Genomic structure of the human BCCIP gene and its expression in cancer. |journal=Gene |volume=302 |issue= 1-2 |pages= 139–46 |year= 2003 |pmid= 12527204 |doi=10.1016/S0378-1119(02)01098-3 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Meng X, Liu J, Shen Z |title=Inhibition of G1 to S cell cycle progression by BCCIP beta. |journal=Cell Cycle |volume=3 |issue= 3 |pages= 343–8 |year= 2004 |pmid= 14726710 |doi= 10.4161/cc.3.3.672}} | ||
*{{cite journal | | *{{cite journal | vauthors=Deloukas P, Earthrowl ME, Grafham DV |title=The DNA sequence and comparative analysis of human chromosome 10. |journal=Nature |volume=429 |issue= 6990 |pages= 375–81 |year= 2004 |pmid= 15164054 |doi= 10.1038/nature02462 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Colland F, Jacq X, Trouplin V |title=Functional proteomics mapping of a human signaling pathway. |journal=Genome Res. |volume=14 |issue= 7 |pages= 1324–32 |year= 2004 |pmid= 15231748 |doi= 10.1101/gr.2334104 | pmc=442148 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Meng X, Lu H, Shen Z |title=BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1. |journal=Cell Cycle |volume=3 |issue= 11 |pages= 1457–62 |year= 2007 |pmid= 15539944 |doi= 10.4161/cc.3.11.1213}} | ||
*{{cite journal | | *{{cite journal | vauthors=Lu H, Guo X, Meng X |title=The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair. |journal=Mol. Cell. Biol. |volume=25 |issue= 5 |pages= 1949–57 |year= 2005 |pmid= 15713648 |doi= 10.1128/MCB.25.5.1949-1957.2005 | pmc=549367 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Stelzl U, Worm U, Lalowski M |title=A human protein-protein interaction network: a resource for annotating the proteome. |journal=Cell |volume=122 |issue= 6 |pages= 957–68 |year= 2005 |pmid= 16169070 |doi= 10.1016/j.cell.2005.08.029 |display-authors=etal}} | ||
*{{cite journal | vauthors=Rual JF, Venkatesan K, Hao T |title=Towards a proteome-scale map of the human protein-protein interaction network. |journal=Nature |volume=437 |issue= 7062 |pages= 1173–8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209 |display-authors=etal}} | |||
*{{cite journal | | *{{cite journal | vauthors=Olsen JV, Blagoev B, Gnad F |title=Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. |journal=Cell |volume=127 |issue= 3 |pages= 635–48 |year= 2006 |pmid= 17081983 |doi= 10.1016/j.cell.2006.09.026 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | vauthors=Meng X, Yue J, Liu Z, Shen Z |title=Abrogation of the transactivation activity of p53 by BCCIP down-regulation. |journal=J. Biol. Chem. |volume=282 |issue= 3 |pages= 1570–6 |year= 2007 |pmid= 17135243 |doi= 10.1074/jbc.M607520200 | pmc=2679999 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Ewing RM, Chu P, Elisma F |title=Large-scale mapping of human protein-protein interactions by mass spectrometry. |journal=Mol. Syst. Biol. |volume=3 |issue= 1|pages= 89 |year= 2007 |pmid= 17353931 |doi= 10.1038/msb4100134 | pmc=1847948 |display-authors=etal}} | ||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{ | <!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | ||
{{ | {{PBB_Controls | ||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-10-stub}} |
Latest revision as of 02:31, 30 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
BRCA2 and CDKN1A-interacting protein is a protein that in humans is encoded by the BCCIP gene.[1][2][3]
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. Several transcript variants encoding different isoforms have been described for this gene.[3]
Interactions
BCCIP has been shown to interact with BRCA2,[1] P21,[2] and PTPmu (PTPRM)[4]
References
- ↑ 1.0 1.1 Liu J, Yuan Y, Huan J, Shen Z (Apr 2001). "Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2". Oncogene. 20 (3): 336–45. doi:10.1038/sj.onc.1204098. PMID 11313963.
- ↑ 2.0 2.1 Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H (Oct 2000). "TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase". J Biol Chem. 275 (40): 31145–54. doi:10.1074/jbc.M003031200. PMID 10878006.
- ↑ 3.0 3.1 "Entrez Gene: BCCIP BRCA2 and CDKN1A interacting protein".
- ↑ Phillips-Mason PJ, Mourton T, Major DL, Brady-Kalnay SM (2008). "BCCIP associates with the receptor protein tyrosine phosphatase PTPmu". J Cell Biochem. 105 (4): 1059–72. doi:10.1002/jcb.21907. PMC 2758318. PMID 18773424.
External links
- Human BCCIP genome location and BCCIP gene details page in the UCSC Genome Browser.
Further reading
- Coleman RA, Rao P, Fogelsong RJ, Bardes ES (1992). "2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes". Biochim. Biophys. Acta. 1125 (2): 203–9. doi:10.1016/0005-2760(92)90046-X. PMID 1571364.
- Machackova E, Damborsky J, Valik D, Foretova L (2002). "Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic". Hum. Mutat. 18 (6): 545. doi:10.1002/humu.1232. PMID 11748848.
- Armakolas A, Ladopoulou A, Konstantopoulou I, et al. (2002). "BRCA2 gene mutations in Greek patients with familial breast cancer". Hum. Mutat. 19 (1): 81–2. doi:10.1002/humu.9003. PMID 11754111.
- Robson M, Scheuer L, Nafa K, et al. (2002). "Unique de novo mutation of BRCA2 in a woman with early onset breast cancer". J. Med. Genet. 39 (2): 126–8. doi:10.1136/jmg.39.2.126. PMC 1735025. PMID 11836363.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Meng X, Liu J, Shen Z (2003). "Genomic structure of the human BCCIP gene and its expression in cancer". Gene. 302 (1–2): 139–46. doi:10.1016/S0378-1119(02)01098-3. PMID 12527204.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Meng X, Liu J, Shen Z (2004). "Inhibition of G1 to S cell cycle progression by BCCIP beta". Cell Cycle. 3 (3): 343–8. doi:10.4161/cc.3.3.672. PMID 14726710.
- Deloukas P, Earthrowl ME, Grafham DV, et al. (2004). "The DNA sequence and comparative analysis of human chromosome 10". Nature. 429 (6990): 375–81. doi:10.1038/nature02462. PMID 15164054.
- Colland F, Jacq X, Trouplin V, et al. (2004). "Functional proteomics mapping of a human signaling pathway". Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Meng X, Lu H, Shen Z (2007). "BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1". Cell Cycle. 3 (11): 1457–62. doi:10.4161/cc.3.11.1213. PMID 15539944.
- Lu H, Guo X, Meng X, et al. (2005). "The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair". Mol. Cell. Biol. 25 (5): 1949–57. doi:10.1128/MCB.25.5.1949-1957.2005. PMC 549367. PMID 15713648.
- Stelzl U, Worm U, Lalowski M, et al. (2005). "A human protein-protein interaction network: a resource for annotating the proteome". Cell. 122 (6): 957–68. doi:10.1016/j.cell.2005.08.029. PMID 16169070.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Meng X, Yue J, Liu Z, Shen Z (2007). "Abrogation of the transactivation activity of p53 by BCCIP down-regulation". J. Biol. Chem. 282 (3): 1570–6. doi:10.1074/jbc.M607520200. PMC 2679999. PMID 17135243.
- Ewing RM, Chu P, Elisma F, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Mol. Syst. Biol. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
This article on a gene on human chromosome 10 is a stub. You can help Wikipedia by expanding it. |